Clinical Trial: Brain Slice Explants to Predict Drug Response in Brain Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Central Nervous System Tumor
Study Type: OBSERVATIONAL
Official Title: A Feasibility Study to Determine if a Novel Patient-derived Explant Platform Can Produce Drug Sensitivity Scores Within a Clinically Relevant Time Frame in Patients With CNS Tumors
Brief Summary:
This biospecimen collection study will evaluate the feasibility of engrafting and testing resected Central nervous system (CNS) tumors tumor tissue ex vivo to estimate drug response, in pediatric and adult subjects.CNS tumors display remarkable heterogeneity and unfortunately there are no reliable precision oncology platforms that can identify the most effective therapy for each patient.Recent work has demonstrated the success of functional precision oncology platforms using patient-derived explant (PDE) at…
Read more